Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival

200936 citationsJournal Article

Authors

Good health and well-being

Published in: Clinical Immunology

Volume 133, Issue 3, pp. 333-352

Field-Weighted Citation Impact: 1.25